West Pharmaceutical Services, Inc. (WST)
USD 216.13
(0.46%)
USD 216.13
(0.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.12 Billion USD | -0.62% |
| 2022 | 1.13 Billion USD | -3.37% |
| 2021 | 1.17 Billion USD | 53.14% |
| 2020 | 767.8 Million USD | 26.76% |
| 2019 | 605.7 Million USD | 11.06% |
| 2018 | 545.4 Million USD | 6.4% |
| 2017 | 512.6 Million USD | 2.29% |
| 2016 | 501.1 Million USD | 9.94% |
| 2015 | 455.8 Million USD | 1.79% |
| 2014 | 447.8 Million USD | 3.01% |
| 2013 | 434.7 Million USD | 12.12% |
| 2012 | 387.7 Million USD | 14.26% |
| 2011 | 339.3 Million USD | 6.66% |
| 2010 | 318.1 Million USD | 4.78% |
| 2009 | 303.6 Million USD | 0.33% |
| 2008 | 302.6 Million USD | 3.7% |
| 2007 | 291.8 Million USD | 11.46% |
| 2006 | 261.8 Million USD | 35.93% |
| 2005 | 192.6 Million USD | 23.54% |
| 2004 | 155.9 Million USD | 0.06% |
| 2003 | 155.8 Million USD | 32.48% |
| 2002 | 117.6 Million USD | 1.29% |
| 2001 | 116.1 Million USD | -17.31% |
| 2000 | 140.4 Million USD | -22.0% |
| 1999 | 180 Million USD | 7.46% |
| 1998 | 167.5 Million USD | 2.13% |
| 1997 | 164 Million USD | 4.59% |
| 1996 | 156.8 Million USD | 6.09% |
| 1995 | 147.8 Million USD | 6.18% |
| 1994 | 139.2 Million USD | 9.95% |
| 1993 | 126.6 Million USD | 5.15% |
| 1992 | 120.4 Million USD | 11.28% |
| 1991 | 108.2 Million USD | 6.39% |
| 1990 | 101.7 Million USD | -0.29% |
| 1989 | 102 Million USD | 12.33% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 231.3 Million USD | 0.48% |
| 2024 Q3 | 264.7 Million USD | 14.44% |
| 2024 Q1 | 230.2 Million USD | -17.25% |
| 2023 Q2 | 291.4 Million USD | 7.41% |
| 2023 Q1 | 271.3 Million USD | 3.51% |
| 2023 FY | 1.12 Billion USD | -0.62% |
| 2023 Q3 | 288.3 Million USD | -1.06% |
| 2023 Q4 | 278.2 Million USD | -3.5% |
| 2022 Q2 | 321.5 Million USD | 12.97% |
| 2022 FY | 1.13 Billion USD | -3.37% |
| 2022 Q1 | 284.6 Million USD | -5.32% |
| 2022 Q4 | 262.1 Million USD | -2.2% |
| 2022 Q3 | 268 Million USD | -16.64% |
| 2021 Q4 | 300.6 Million USD | 4.3% |
| 2021 FY | 1.17 Billion USD | 53.14% |
| 2021 Q1 | 271.9 Million USD | 28.8% |
| 2021 Q2 | 315.1 Million USD | 15.89% |
| 2021 Q3 | 288.2 Million USD | -8.54% |
| 2020 FY | 767.8 Million USD | 26.76% |
| 2020 Q2 | 195.1 Million USD | 16.83% |
| 2020 Q1 | 167 Million USD | 9.01% |
| 2020 Q3 | 194.6 Million USD | -0.26% |
| 2020 Q4 | 211.1 Million USD | 8.48% |
| 2019 Q2 | 157.9 Million USD | 7.56% |
| 2019 Q1 | 146.8 Million USD | 10.21% |
| 2019 Q3 | 147.8 Million USD | -6.4% |
| 2019 Q4 | 153.2 Million USD | 3.65% |
| 2019 FY | 605.7 Million USD | 11.06% |
| 2018 Q4 | 133.2 Million USD | -1.77% |
| 2018 Q1 | 134.4 Million USD | 4.59% |
| 2018 Q2 | 142.2 Million USD | 5.8% |
| 2018 Q3 | 135.6 Million USD | -4.64% |
| 2018 FY | 545.4 Million USD | 6.4% |
| 2017 Q2 | 125 Million USD | -6.79% |
| 2017 Q1 | 134.1 Million USD | 8.67% |
| 2017 Q3 | 125 Million USD | 0.0% |
| 2017 Q4 | 128.5 Million USD | 2.8% |
| 2017 FY | 512.6 Million USD | 2.29% |
| 2016 Q2 | 133.3 Million USD | 8.11% |
| 2016 FY | 501.1 Million USD | 9.94% |
| 2016 Q3 | 121.1 Million USD | -9.15% |
| 2016 Q1 | 123.3 Million USD | 3.09% |
| 2016 Q4 | 123.4 Million USD | 1.9% |
| 2015 Q1 | 109.7 Million USD | 0.0% |
| 2015 FY | 455.8 Million USD | 1.79% |
| 2015 Q2 | 118.2 Million USD | 7.75% |
| 2015 Q3 | 108.3 Million USD | -8.38% |
| 2015 Q4 | 119.6 Million USD | 10.43% |
| 2014 Q3 | 109.9 Million USD | -9.77% |
| 2014 FY | 447.8 Million USD | 3.01% |
| 2014 Q1 | 106.4 Million USD | -0.19% |
| 2014 Q2 | 121.8 Million USD | 14.47% |
| 2014 Q4 | 109.7 Million USD | -0.18% |
| 2013 Q3 | 105.5 Million USD | -4.87% |
| 2013 FY | 434.7 Million USD | 12.12% |
| 2013 Q4 | 106.6 Million USD | 1.04% |
| 2013 Q2 | 110.9 Million USD | -0.72% |
| 2013 Q1 | 111.7 Million USD | 14.56% |
| 2012 Q1 | 101.1 Million USD | 18.52% |
| 2012 FY | 387.7 Million USD | 14.26% |
| 2012 Q2 | 98.7 Million USD | -2.37% |
| 2012 Q4 | 97.5 Million USD | 7.85% |
| 2012 Q3 | 90.4 Million USD | -8.41% |
| 2011 FY | 339.3 Million USD | 6.66% |
| 2011 Q1 | 88 Million USD | 12.82% |
| 2011 Q2 | 84.6 Million USD | -3.86% |
| 2011 Q3 | 81.4 Million USD | -3.78% |
| 2011 Q4 | 85.3 Million USD | 4.79% |
| 2010 Q1 | 82.2 Million USD | -2.03% |
| 2010 FY | 318.1 Million USD | 4.78% |
| 2010 Q4 | 78 Million USD | 4.42% |
| 2010 Q3 | 74.7 Million USD | -10.22% |
| 2010 Q2 | 83.2 Million USD | 1.22% |
| 2009 Q3 | 71.7 Million USD | -8.89% |
| 2009 Q4 | 83.9 Million USD | 17.02% |
| 2009 FY | 303.6 Million USD | 0.33% |
| 2009 Q2 | 78.7 Million USD | 13.56% |
| 2009 Q1 | 69.3 Million USD | -0.43% |
| 2008 Q3 | 66 Million USD | -21.05% |
| 2008 Q4 | 69.6 Million USD | 5.45% |
| 2008 Q1 | 83.5 Million USD | 18.44% |
| 2008 FY | 302.6 Million USD | 3.7% |
| 2008 Q2 | 83.6 Million USD | 0.12% |
| 2007 Q2 | 76.7 Million USD | -4.6% |
| 2007 Q4 | 70.5 Million USD | 9.64% |
| 2007 Q1 | 80.4 Million USD | 22.56% |
| 2007 FY | 291.8 Million USD | 11.46% |
| 2007 Q3 | 64.3 Million USD | -16.17% |
| 2006 Q4 | 65.6 Million USD | 11.56% |
| 2006 Q1 | 66.9 Million USD | 29.15% |
| 2006 FY | 261.8 Million USD | 35.93% |
| 2006 Q2 | 70.5 Million USD | 5.38% |
| 2006 Q3 | 58.8 Million USD | -16.6% |
| 2005 Q3 | 43.8 Million USD | -13.44% |
| 2005 FY | 192.6 Million USD | 23.54% |
| 2005 Q4 | 51.8 Million USD | 18.26% |
| 2005 Q2 | 50.6 Million USD | 9.05% |
| 2005 Q1 | 46.4 Million USD | 29.61% |
| 2004 Q3 | 36.7 Million USD | -14.25% |
| 2004 FY | 155.9 Million USD | 0.06% |
| 2004 Q2 | 42.8 Million USD | 5.42% |
| 2004 Q4 | 35.8 Million USD | -2.45% |
| 2004 Q1 | 40.6 Million USD | -3.79% |
| 2003 Q3 | 35.8 Million USD | -13.53% |
| 2003 FY | 155.8 Million USD | 32.48% |
| 2003 Q2 | 41.4 Million USD | 13.74% |
| 2003 Q1 | 36.4 Million USD | 27.72% |
| 2003 Q4 | 42.2 Million USD | 17.88% |
| 2002 Q3 | 26.7 Million USD | -13.87% |
| 2002 FY | 117.6 Million USD | 1.29% |
| 2002 Q1 | 31.4 Million USD | 21.71% |
| 2002 Q2 | 31 Million USD | -1.27% |
| 2002 Q4 | 28.5 Million USD | 6.74% |
| 2001 Q3 | 28 Million USD | -11.39% |
| 2001 Q4 | 25.8 Million USD | -7.86% |
| 2001 Q1 | 30.7 Million USD | -48.32% |
| 2001 Q2 | 31.6 Million USD | 2.93% |
| 2001 FY | 116.1 Million USD | -17.31% |
| 2000 Q3 | 24.6 Million USD | -12.77% |
| 2000 Q1 | 28.2 Million USD | -60.56% |
| 2000 FY | 140.4 Million USD | -22.0% |
| 2000 Q2 | 28.2 Million USD | 0.0% |
| 2000 Q4 | 59.4 Million USD | 141.46% |
| 1999 Q4 | 71.5 Million USD | 108.45% |
| 1999 Q1 | 34.4 Million USD | -49.41% |
| 1999 Q2 | 39.8 Million USD | 15.7% |
| 1999 Q3 | 34.3 Million USD | -13.82% |
| 1999 FY | 180 Million USD | 7.46% |
| 1998 Q4 | 68 Million USD | 103.59% |
| 1998 Q3 | 33.4 Million USD | -4.02% |
| 1998 FY | 167.5 Million USD | 2.13% |
| 1998 Q1 | 31.3 Million USD | -52.43% |
| 1998 Q2 | 34.8 Million USD | 11.18% |
| 1997 Q3 | 29.2 Million USD | -19.56% |
| 1997 FY | 164 Million USD | 4.59% |
| 1997 Q1 | 32.7 Million USD | -48.91% |
| 1997 Q2 | 36.3 Million USD | 11.01% |
| 1997 Q4 | 65.8 Million USD | 125.34% |
| 1996 Q1 | 31.3 Million USD | -46.68% |
| 1996 Q3 | 29.6 Million USD | -7.21% |
| 1996 Q4 | 64 Million USD | 116.22% |
| 1996 FY | 156.8 Million USD | 6.09% |
| 1996 Q2 | 31.9 Million USD | 1.92% |
| 1995 Q3 | 24.7 Million USD | -22.57% |
| 1995 Q1 | 32.1 Million USD | -41.74% |
| 1995 Q2 | 31.9 Million USD | -0.62% |
| 1995 Q4 | 58.7 Million USD | 137.65% |
| 1995 FY | 147.8 Million USD | 6.18% |
| 1994 Q3 | 25.4 Million USD | -14.77% |
| 1994 Q4 | 55.1 Million USD | 116.93% |
| 1994 FY | 139.2 Million USD | 9.95% |
| 1994 Q1 | 28.9 Million USD | -43.88% |
| 1994 Q2 | 29.8 Million USD | 3.11% |
| 1993 FY | 126.6 Million USD | 5.15% |
| 1993 Q1 | 24.1 Million USD | -49.58% |
| 1993 Q2 | 26.9 Million USD | 11.62% |
| 1993 Q3 | 24.1 Million USD | -10.41% |
| 1993 Q4 | 51.5 Million USD | 113.69% |
| 1992 FY | 120.4 Million USD | 11.28% |
| 1992 Q4 | 47.8 Million USD | 115.32% |
| 1992 Q3 | 22.2 Million USD | -13.62% |
| 1992 Q2 | 25.7 Million USD | 5.33% |
| 1992 Q1 | 24.4 Million USD | -44.92% |
| 1991 Q3 | 19.8 Million USD | -7.48% |
| 1991 Q2 | 21.4 Million USD | -6.14% |
| 1991 Q1 | 22.8 Million USD | -46.73% |
| 1991 FY | 108.2 Million USD | 6.39% |
| 1991 Q4 | 44.3 Million USD | 123.74% |
| 1990 Q4 | 42.8 Million USD | 144.57% |
| 1990 Q1 | 22.5 Million USD | -71.77% |
| 1990 FY | 101.7 Million USD | -0.29% |
| 1990 Q3 | 17.5 Million USD | -8.85% |
| 1990 Q2 | 19.2 Million USD | -14.67% |
| 1989 FY | 102 Million USD | 12.33% |
| 1989 Q2 | 79.5 Million USD | -0.75% |
| 1989 Q1 | 80.1 Million USD | 6.23% |
| 1989 Q3 | 69.4 Million USD | -12.7% |
| 1989 Q4 | 79.7 Million USD | 14.84% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alcon Inc. | 5.6 Billion USD | 79.864% |
| AptarGroup, Inc. | 1.26 Billion USD | 10.622% |
| Baxter International Inc. | 4.97 Billion USD | 77.303% |
| Becton, Dickinson and Company | 9.15 Billion USD | 87.663% |
| Bausch + Lomb Corporation | 2.5 Billion USD | 54.904% |
| Haemonetics Corporation | 676.53 Million USD | -66.909% |
| Envista Holdings Corp | 1.45 Billion USD | 22.151% |
| ResMed Inc. | 2.6 Billion USD | 56.715% |
| Teleflex Incorporated | 1.64 Billion USD | 31.436% |
| Warby Parker Inc. | 365.22 Million USD | -209.18% |